Related Experiment Videos
Reversal of postburn immunosuppression with low-dose polymyxin B
Abstract:
In a randomized study of 28 patients with thermal injury, polymyxin B was administered intravenously in small doses to attempt to block the immunosuppressive effects of endotoxin. When compared with controls, treated patients showed a reduction in septic complications and death, but this reduction is not statistically significant at this time. In vitro measurements of lymphocyte function, however, indicate a statistically significant improvement in the T helper to suppressor ratio, and in the lymphocyte responsiveness to a number of bacterial antigens.
Insights
Polymyxin B may improve immune function in burn patients by enhancing T-helper cells and lymphocyte response to antigens. Further research is needed to confirm its impact on reducing septic complications and mortality.
Area of Science:
- Immunology
- Burn Injury Management
- Pharmacology
Background:
- Thermal injuries can lead to immunosuppression, increasing the risk of sepsis and death.
- Endotoxin plays a significant role in the immunosuppressive effects observed in burn patients.
Purpose of the Study:
- To investigate the potential of polymyxin B to counteract endotoxin-induced immunosuppression in patients with thermal injury.
- To evaluate the impact of low-dose intravenous polymyxin B on septic complications, mortality, and immune cell function.
Main Methods:
- A randomized study involving 28 patients with thermal injury.
- Intravenous administration of small doses of polymyxin B.
- In vitro assessment of lymphocyte function, including T helper to suppressor ratio and responsiveness to bacterial antigens.
Main Results:
- A trend towards reduced septic complications and death was observed in the polymyxin B treated group compared to controls, though not statistically significant.
- Statistically significant improvements were noted in vitro for the T helper to suppressor ratio.
- Enhanced lymphocyte responsiveness to bacterial antigens was observed in treated patients.
Conclusions:
- Low-dose polymyxin B may offer immunomodulatory benefits in thermal injury patients by improving lymphocyte function.
- While not statistically significant in this small cohort, polymyxin B warrants further investigation for its potential to reduce sepsis and mortality in burn patients.